How much of the protein control is more appropriate for kidney patients?

Targets for protein control for kidney patients vary from person to person, depending on the patient ‘ s specific condition, the extent of kidney damage and other complications.I. Relationship between protein urine and kidney diseasesProtein urine refers to the excretion of proteins in urine above normal values, which is an important indicator of kidney disease. Under normal circumstances, the filtration of kidneys can be effective in preventing the passage of large molecular proteins, but the filtration is impaired in cases of renal disease, leading to the leakage of proteins into urine. Long-term protein urine not only reflects kidney damage but also exacerbates the progress of kidney disease.Importance of protein quantitative controlControlling protein urine to the desired level is important to slow the progress of kidney diseases. Excessive protein urine increases the internal pressure of the kidney ball, damages the kidney ball to the filament, and further exacerbates the kidney damage. Therefore, reducing the level of protein urine is one of the key objectives of the treatment of kidney diseases.III. Protein quantitative control objectivesLight protein urine: urine protein excretion < 1 g/day. For patients with mild protein urine, the target is usually maintained at or below this level.Moderate protein urine: urine protein excretion between 1 g/day and 3.5 g/day. Such patients should reduce their protein urine to less than 1 g/day.Large amounts of protein urine: Uterary protein excretion exceeding 3.5 g/d. The treatment target is to reduce protein urine to less than 3.5 g/day and ideally to less than 1 g/day.IV. Targets for individualized treatmentControl objectives for protein urine should take into account individual differences among patients, including age, gender, kidney function level, and other complications. The following are some specific cases:Diabetes nephrosis: The American Diabetes Association recommended keeping urine protein excretion below 500 mg/day.Children ' s kidney disease: Protein urine control targets for children ' s kidney disease may be stricter to reduce the risk of long-term complications.TreatmentLifestyle adjustments: include low salt diets, reduction of protein intake, weight control, avoidance of smoking and excessive alcohol consumption.Drug treatment: ACE inhibitors or ARB-type drugs are commonly used as therapeutic drugs that reduce blood pressure and protein urine.Immunosuppressive treatment: For some primary kidney spherical diseases, such as membrane kidney diseases, immunosuppressants may be used to reduce protein urine.Monitoring and follow-upRenal patients should undergo periodic urine protein ration tests to monitor the effects of treatment. During treatment, treatment programmes may need to be adapted to achieve optimal protein urine control.ConclusionThe extent to which proteomic control of kidney patients is appropriate needs to be determined on the basis of the patient ' s specific circumstances and the doctor ' s advice. In general, the control of urinary protein excretion below 1 g/day is the target of treatment, but it may be adjusted for different types of kidney diseases and for patients at different stages. Through effective treatment and improved lifestyles, the levels of protein urine can be reduced, the progress of kidney diseases can be reduced and the kidney function protected. Patients should work closely with doctors and follow individualized treatment programmes to achieve optimal treatment.